Pubblicazioni IOV anno corrente 2020
TitoloAutoriRivista
Health outcomes and direct healthcare costs in patients with Melanoma: Associations with level of educationBuja,A., Rivera,M., Zorzi,M., Sperotto,M., Baracco,S., Italiano,I., Vecchiato Antonella, Del Fiore Santo Paolo, Avossa,F., Corti,M. C., Guzzinati,S., Saia,M., Baldo,V., Rugge,M., Rossi Carlo RiccardoActa Dermato-Venereologica
Metabolism in the Tumor MicroenvironmentMontenegro,F., Indraccolo StefanoAdvances in Experimental Medicine and Biology
Effectiveness of CBCT imaging during radiotherapy for the detection of initial COVID-19 lung diseaseSepulcri Matteo, Paronetto,C., El Khouzai,B., Novo,A., Aldegheri,V., Scaggion Alessandro, Fusella MarcoAdvances in radiation oncology
A case of 'double hit' mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinibScapinello,G., Riva,M., Branca,A., Pizzi,M., Bonaldi Laura, Martines Annalisa, Manni,S., Visentin,A., Trentin,L., Semenzato,G., Gurrieri,C., Piazza,F.Annals of hematology
An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45Bjelic-Radisic,V., Cardoso,F., Cameron,D., Brain,E., Kuljanic,K., da Costa,R. A., Conroy,T., Inwald,E. C., Serpentini Samantha, Pinto,M., Weis,J., Morag,O., Lindviksmoen Astrup,G., Tomaszweksi,K. A., Pogoda,K., Sinai,P., Sprangers,M., Aaronson,N., Velikova,G., Greimel,E. (...)Annals of Oncology
ESMO consensus conference recommendations on the management of locoregional melanoma: the ESMO Guidelines CommitteeMichielin,O., van Akkooi,A., Lorigan,P., Ascierto,P. A., Dummer,R., Robert,C., Arance,A., Blank,C. U., Chiarion-Sileni Vanna, Donia,M., Faries,M. B., Gaudy-Marqueste,C., Gogas,H., Grob,J. J., Guckenberger,M., Haanen,J., Hayes,A. J., Hoeller,C., Lebbé,C., Lugowska,I. (...)Annals of Oncology
ESMO consensus conference recommendations on the management of metastatic melanoma: the ESMO Guidelines CommitteeKeilholz,U., Ascierto,P. A., Dummer,R., Robert,C., Lorigan,P., van Akkooi,A., Arance,A., Blank,C. U., Chiarion-Sileni Vanna, Donia,M., Faries,M. B., Gaudy-Marqueste,C., Gogas,H., Grob,J. J., Guckenberger,M., Haanen,J., Hayes,A. J., Hoeller,C., Lebbé,C., Lugowska,I. (...)Annals of Oncology
Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT databaseSalem,M. E., Yin,J., Goldberg,R. M., Pederson,L. D., Wolmark,N., Alberts,S. R., Taieb,J., Marshall,J. L., Lonardi Sara, Yoshino,T., Kerr,R. S., Yothers,G., Grothey,A., Andre,T., De Gramont,A., Shi,Q.Annals of Oncology
On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2Caffo,O., Zagonel Vittorina, Baldessari,C., Berruti,A., Bortolus,R., Buti,S., Ceresoli,G. L., Donini,M., Ermacora,P., Fornarini,G., Fratino,L., Masini,C., Massari,F., Mosca,A., Mucciarini,C., Procopio,G., Tucci,M., Verri,E., Zucali,P., Buttigliero,C. (...)Annals of Oncology
Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancerRugo,H. S., Andrè,F., Yamashita,T., Cerda,H., Toledano,I., Stemmer,S. M., Jurado,J. C., Juric,D., Mayer,I., Ciruelos,E. M., Iwata,H., Conte PierFranco, Campone,M., Wilke,C., Mills,D., Lteif,A., Miller,M., Gaudenzi,F., Loibl,S.Annals of Oncology
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancerRobson,M. E., Tung,N., Conte PierFranco, Im,S. A., Senkus,E., Xu,B., Masuda,N., Delaloge,S., Li,W., Armstrong,A., Wu,W., Goessl,C., Runswick,S., Domchek,S. M.Annals of Oncology
Lasting Symptoms After Esophageal Resection (LASER): European Multicenter Cross-sectional StudyMarkar,S. R., Zaninotto,G., Castoro,C., Johar,A., Lagergren,P., Elliott,J. A., Gisbertz,S. S., Mariette,C., Alfieri Rita, Huddy,J., Sounderajah,V., Pinto Eleonora, Scarpa,M., Klevebro,F., Sunde,B., Murphy,C. F., Greene,C., Ravi,N., Piessen,G., Brenkman,H. (...)Annals of surgery
Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumabCaccese Mario, Barbot,M., Ceccato,F., Padovan,M., Gardiman,M. P., Fassan,M., Denaro,L., Emanuelli,E., D'Avella,D., Scaroni,C., Zagonel Vittorina, Lombardi GiuseppeAnti-Cancer Drugs
Nanoparticles as tools to target redox homeostasis in cancer cellsCiccarese Francesco, Raimondi Vittoria, Sharova Evgeniya, Silic-Benussi Micol, Ciminale VincenzoAntioxidants
Laparoscopic hyperthermic intraperitoneal chemotherapy for appendiceal tumorsSommariva Antonio, Tonello Marco, De Simoni,O., Barina,A., Rossi Carlo Riccardo, Pilati PierluigiAsian journal of endoscopic surgery
Impact of the COVID-19 pandemic on urological practice in emergency departments in ItalyNovara,G., Bartoletti,R., CRESTANI ALESSANDRO, De Nunzio,C., Durante,J., Gregori,A., Liguori,G., Pavan,N., Trombetta,C., Simonato,A., Tubaro,A., Ficarra,V., Porpiglia,F., members of the Research Urology Network (RUN) (seeBJU international
Identification of the true hyperdiploid multiple myeloma subset by combining conventional karyotyping and FISH analysisBarilà ,G., Bonaldi Laura, Grassi Angela, Martines Annalisa, Lico,A., Macrì,N., Nalio Silvia, Pavan,L., Berno,T., Branca,A., Calabretto,G., Carrino,M., Teramo,A., Manni,S., Piazza,F., Semenzato,G., Zambello,R.Blood Cancer Journal
AtezoTRIBE: A randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancerAntoniotti,C., Borelli,B., Rossini,D., Pietrantonio,F., Morano,F., Salvatore,L., Lonardi Sara, Marmorino,F., Tamberi,S., Corallo,S., Tortora,G., Bergamo Francesca, Brunella,D. S., Boccaccino,A., Grassi,E., Racca,P., Tamburini,E., Aprile,G., Moretto,R., Boni,L. (...)BMC cancer
Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimensWainberg,Z. A., Feeney,K., Lee,M. A., Munoz,A., Gracian,A. C., Lonardi Sara, Ryoo,B. Y., Hung,A., Lin,Y., Bendell,J., Hecht,J. R.BMC cancer
Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: A multi-cycle, phase II studyCaputo,R., Cazzaniga,M. E., Sbrana,A., Torrisi,R., Paris,I., Giordano,M., Montesarchio,V., Guarneri Valentina, Amaducci,L., Bilancia,D., Cilenti,G., Fabi,A., Collovà,E., Schirone,A., Bonizzoni,E., Celio,L., De Placido,S., De Laurentiis,M.BMC cancer
Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): A study protocolBongiovanni,A., Liverani,C., Pusceddu,S., Leo,S., Di Meglio,G., Tamberi,S., Santini,D., Gelsomino,F., Pucci,F., Berardi,R., Lolli,I., Bergamo Francesca, Ricci,S., Foca,F., Severi,S., Ibrahim,T.BMJ Open
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological modelCarbognin,L., Simbolo,M., Caliò,A., Vicentini,C., Delfino,P., Sperduti,I., Fassan,M., Schettini,F., Dieci Maria Vittoria, Griguolo Gaia, Pilotto,S., Fiorio,E., Arpino,G., Guarneri Valentina, De Placido,S., Conte PierFranco, Manfrin,E., Brunelli,M., Scambia,G., Scarpa,A. (...)Breast
EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancerBiganzoli,L., Cinieri,S., Berardi,R., Pedersini,R., McCartney,A., Minisini,A. M., Caremoli,E. R., Spazzapan,S., Magnolfi,E., Brunello Antonella, Risi,E., Palumbo,R., Leo,S., Colleoni,M., Donati,S., De Placido,S., Orlando,L., Pistelli,M., Parolin,V., Mislang,A. (...)Breast cancer research : BCR
Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trialGennari,A., Foca,F., Zamarchi Rita, Rocca,A., Amadori,D., De Censi,A., Bologna,A., Cavanna,L., Gianni,L., Scaltriti,L., Rossi Elisabetta, Facchinetti Antonella, Martini,V., Bruzzi,P., Nanni,O.Breast cancer research and treatment
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancerZulato Elisabetta, Attili,I., Pavan,A., Nardo Giorgia, Del Bianco Paola, Boscolo Bragadin,A., Verza Martina, Pasqualini Lorenza, Pasello Giulia, Fassan,M., Calabrese,F., Guarneri Valentina, Amadori Alberto, Conte PierFranco, Indraccolo Stefano, Bonanno LauraBritish Journal of Cancer
miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancerBarisciano,G., Colangelo,T., Rosato,V., Muccillo,L., Taddei,M. L., Ippolito,L., Chiarugi,P., Galgani,M., Bruzzaniti,S., Matarese,G., Fassan,M., Agostini,M., Bergamo Francesca, Pucciarelli,S., Carbone,A., Mazzoccoli,G., Colantuoni,V., Bianchi,F., Sabatino,L.British Journal of Cancer
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trialsFucà ,G., Guarini,V., Antoniotti,C., Morano,F., Moretto,R., Corallo,S., Marmorino,F., Lonardi Sara, Rimassa,L., Sartore-Bianchi,A., Borelli,B., Tampellini,M., Bustreo,S., Claravezza,M., Boccaccino,A., Murialdo,R., Zaniboni,A., Tomasello,G., Loupakis Fotios, Adamo,V. (...)British Journal of Cancer
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trialVaidya,J. S., Bulsara,M., Baum,M., Wenz,F., Massarut,S., Pigorsch,S., Alvarado,M., Douek,M., Saunders,C., Flyger,H. L., Eiermann,W., Brew-Graves,C., Williams,N. R., Potyka,I., Roberts,N., Bernstein,M., Brown,D., Sperk,E., Laws,S., Sütterlin,M. (...)British Medical Journal - BMJ
Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancerConte PierFranco, Schneeweiss,A., Loibl,S., Mamounas,E. P., von Minckwitz,G., Mano,M. S., Untch,M., Huang,C. S., Wolmark,N., Rastogi,P., D'Hondt,V., Redondo,A., Stamatovic,L., Bonnefoi,H., Castro-Salguero,H., Fischer,H. H., Wahl,T., Song,C., Boulet,T., Trask,P. (...)Cancer
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancerFanelli,G. N., Dal Pozzo,C. A., Depretis Ilaria, Schirripa Marta, Brignola,S., Biason Paola, Balistreri,M., Dal Santo,L., Lonardi Sara, Munari Giada, Loupakis Fotios, Fassan,M.Cancer Cell International
Germline polymorphisms of circadian genes and gastric cancer predispositionRajendran,S., Benna,C., Marchet,A., Nitti,D., Mocellin SimoneCancer Communications
The Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophagesMarigo Ilaria , Trovato,R., Hofer,F., Ingangi Vincenzo, DE Sanctis,F., Ugel,S., Cane,S., Simonelli,A., Lamolinara,A., Iezzi,M., Fassan,M., Rugge,M., Boschi,F., Borile,G., Eisenhaure,T., Sarkizova,S., Lieb,D., Hacohen,N., Azzolin,L., Piccolo,S. (...)Cancer Discovery
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective studyButi,S., Bersanelli,M., Viansone,A., Leonetti,A., Masini,C., Ratta,R., Procopio,G., Maines,F., Iacovelli,R., Ciccarese,C., Vitale,M. G., De Giorgi,U., Mucciarini,C., Maruzzo Marco, Prati,G., Lattanzi,E., Ciammella,P., Bruni,A., Andreani,S., D'Abbiero,N. (...)Cancer Treatment and Research Communications
Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptorsDieci Maria Vittoria, Miglietta,F., Griguolo Gaia, Guarneri ValentinaCancer treatment reviews
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysisSchettini,F., Pascual,T., Conte,B., Chic,N., Brasó-Maristany,F., Galvàn,P., Martìnez,O., Adamo,B., Vidal,M., Muñoz,M., Fernàndez-Martinez,A., Rognoni,C., Griguolo Gaia, Guarneri Valentina, Conte PierFranco, Locci,M., Brase,J. C., Gonzalez-Farre,B., Villagrasa,P., De Placido,S. (...)Cancer treatment reviews
Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancerPasello Giulia, Pavan,A., Attili,I., Bortolami Alberto, Bonanno Laura, Menis Jessica, Conte PierFranco, Guarneri ValentinaCancer treatment reviews
Anti-Proliferative and Pro-Apoptotic Effects of Short-Term Inhibition of Telomerase In Vivo and in Human Malignant B Cells Xenografted in ZebrafishGiunco,S., Zangrossi,M., Dal Pozzolo,F., Celeghin,A., Ballin,G., Petrara,M. R., Amin,A., Argenton,F., Godinho Ferreira,M., De Rossi AnitaCancers
Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast CancerBrisotto,G., Biscontin,E., Rossi Elisabetta, Bulfoni,M., Piruska,A., Spazzapan,S., Poggiana Cristina, Vidotto Riccardo, Steffan,A., Colombatti,A., Huck,W. T. S., Cesselli,D., Zamarchi Rita, Turetta,M., Del Ben,F.Cancers
Erbb2 mrna expression and response to ado-trastuzumab emtansine (T-dm1) in her2-positive breast cancerGriguolo Gaia, Brasò-Maristany,F., Gonzàlez-Farrè,B., Pascual,T., Chic,N., Saurì­,T., Kates,R., Gluz,O., Martìnez,D., Parè,L., Tsvetkova,V., Pesantez,D., Vidal,M., Adamo,B., Munoz,M., Galvàn,P., Barberà,L., Cuatrecasas,M., Christgen,M., Kreipe,H. (...)Cancers
From central to sentral (Serum angiogenesis central): Circulating predictive biomarkers to anti-VEGFR therapyGiampieri,R., Ziranu,P., Daniele,B., Zizzi,A., Ferrari,D., Lonardi Sara, Zaniboni,A., Cavanna,L., Rosati,G., Casagrande,M., Pella,N., Demurtas,L., Zampino,M. G., Sozzi,P., Pusceddu,V., Germano,D., Lai,E., Zagonel Vittorina, Libertini,M., Puzzoni,M. (...)Cancers
Novel nuclear medicine imaging applications in immuno-oncologyFrega Stefano, Maso,A. D., Pasello Giulia, Cuppari,L., Bonanno Laura, Conte PierFranco, Evangelista,L.Cancers
Patient-derived scaffolds of colorectal cancer metastases as an organotypic 3D model of the liver metastatic microenvironmentD'angelo,E., Natarajan,D., Sensi,F., Ajayi,O., Fassan,M., Mammano E, Pilati Pierluigi, Pavan,P., Bresolin,S., Preziosi,M., Miquel,R., Zen,Y., Chokshi,S., Menon,K., Heaton,N., Spolverato,G., Piccoli,M., Williams,R., Urbani,L., Agostini,M. (...)Cancers
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot StudyLombardi Giuseppe, Barresi,V., Indraccolo Stefano, Simbolo,M., Fassan,M., Mandruzzato Susanna, Simonelli,M., Caccese Mario, Pizzi,M., Fassina,A., Padovan,M., Masetto Elena, Gardiman,M. P., Bonavina Maria Giuseppina, Caffo,M., Persico,P., Chioffi,F., Denaro,L., Dei Tos,A. P., Scarpa,A. (...)Cancers
Reactive oxygen species and antitumor immunity- from surveillance to evasionKotsafti Andromachi, Scarpa,M., Castagliuolo,I., Scarpa MelaniaCancers
Reactive Oxygen Species and Antitumor Immunity-From Surveillance to EvasionKotsafti Andromachi, Scarpa,M., Castagliuolo,I., Scarpa MelaniaCancers
Single Nucleotide Polymorphisms in MiRNA Binding Sites of Nucleotide Excision Repair-Related Genes Predict Clinical Benefit of Oxaliplatin in FOLFOXIRI Plus Bevacizumab: Analysis of the TRIBE TrialSuenaga,M., Schirripa Marta, Cao,S., Zhang,W., Yang,D., Cremolini,C., Murgioni Sabina, Lonardi Sara, Ning,Y., Okazaki,S., Berger,M. D., Miyamoto,Y., Barzi,A., Loupakis Fotios, Falcone,A., Lenz,H. J.Cancers
TERT promoter mutations differently correlate with the clinical outcome of MAPK inhibitor-treated melanoma patientsDel Bianco Paola, Stagni,C., Giunco,S., Fabozzi Alessio, Elefanti Lisa, Pellegrini,S., Vecchiato Antonella, Pigozzo Jacopo, Zamuner Carolina, De Rossi Anita, De Nicolo Arcangela, Menin ChiaraCancers
The Pathologic and Molecular Landscape of Esophageal Squamous Cell CarcinogenesisBusinello,G., Parente,P., Mastracci,L., Pennelli,G., Traverso Giulia, Milione,M., Bellan,E., Michelotto,M., Kotsafti Andromachi, Grillo,F., Fassan,M.Cancers
TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard ChemotherapyGraziano,F., Fischer,N. W., Bagaloni,I., Di Bartolomeo,M., Lonardi Sara, Vincenzi,B., Perrone,G., Fornaro,L., Ongaro,E., Aprile,G., Bisonni,R., Prisciandaro,M., Malkin,D., Garièpy,J., Fassan,M., Loupakis Fotios, Sarti,D., Del Prete,M., Catalano,V., Alessandroni,P. (...)Cancers
Parathyroidectomy Resolves Tooth Discoloration: A New Presenting Sign of Hyperparathyroidism?Musacchio,E., Piotto,A., Binotto,P., Toniato Antonio, Sartori,L.Case Reports in Dentistry
A simple method for detecting oncofetal chondroitin sulfate glycosaminoglycans in bladder cancer urineClausen,T. M., Kumar,G., Ibsen,E. K., Orum-Madsen,M. S., Hurtado-Coll,A., Gustavsson,T., Agerbaek,M. Ø., Gatto,F., Todenhofer,T., Basso Umberto, Knowles,M. A., Sanchez-Carbayo,M., Salanti,A., Black,P. C., Daugaard,M.Cell Death Discovery
Anti-PSMA CAR-engineered NK-92 Cells: An Off-the-shelf Cell Therapy for Prostate CancerMontagner Monia Isabella, Penna,A., Fracasso,G., Carpanese Debora, Pietà,A. D., Barbieri,V., Zuccolotto,G., Rosato AntonioCells
miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic LeukemiaSaccomani,V., Grassi Angela, Piovan Erich, Bongiovanni,D., Di Martino,L., Minuzzo,S., Tosello Valeria, Zanovello PaolaCells
Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET populationCiruelos,E., Jerusalem,G., Martin,M., Tjan-Heijnen,V., Neven,P., Gavila,J., Montemurro,F., Generali,D., Lang,I., Martì­nez-Serrano,M. J., Perellò,M. F., Conte PierFrancoClinical & Translational Oncology
Neutrophil-to-lymphocyte ratio and lactate dehydrogenase as biomarkers for urothelial cancer treated with immunotherapyBanna,G. L., Di Quattro,R., Malatino,L., Fornarini,G., Addeo,A., Maruzzo Marco, Urzia,V., Rundo,F., Lipari,H., De Giorgi,U., Basso UmbertoClinical & Translational Oncology
Head-to-head comparison between 18F-FDG PET/CT and PET/MRI in breast cancerEvangelista Laura, Cuppari Lea, Burei Marta, Zorz Alessandra, Caumo FrancescaClinical and Translational Imaging
Targeting prostate cancer with the anti-PSMA scFvD2B: a theranostic promise for nuclear medicineCarpanese Debora, Zorz Alessandra, Evangelista Laura, Salvarese,N.Clinical and Translational Imaging
Cell membrane protein functionalization of nanoparticles as a new tumor-targeting strategyPastò Anna, Giordano,F., Evangelopoulos,M., Amadori Alberto, Tasciotti,E.Clinical and translational medicine
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE StudyCasadei-Gardini,A., Marisi,G., Dadduzio Vincenzo, Gramantieri,L., Faloppi,L., Ulivi,P., Foschi,F. G., Tamburini,E., Vivaldi,C., Rizzato,M. D., Ielasi,L., Canale,M., Conti,F., Rudnas,B., Fornaro,L., Silvestris,N., Silletta,M., Cardellino,G. G., Lonardi Sara, Fornari,F. (...)Clinical Cancer Research
Periostin and Epithelial-Mesenchymal Transition Score as Novel Prognostic Markers for Leiomyosarcoma, Myxofibrosarcoma, and Undifferentiated Pleomorphic SarcomaPiano Maria Assunta, Brunello Antonella, Cappellesso,R., Del Bianco Paola, Mattiolo,A., Fritegotto Chiara, Montini,B., Zamuner Carolina, Del Fiore Santo Paolo, Rastrelli Marco, Sommariva Antonio CH ESOFAGO, De Salvo Gian Luca, Montesco Maria Cristina, Rossi Carlo Riccardo, Zagonel Vittorina, Calabrò Maria LuisaClinical Cancer Research
Phosphorylated Acetyl-CoA Carboxylase Is Associated with Clinical Benefit with Regorafenib in Relapsed Glioblastoma: REGOMA Trial Biomarker AnalysisIndraccolo Stefano, De Salvo Gian Luca, Verza,M., Caccese Mario, Esposito Giovanni, Piga,I., Del Bianco Paola, Pizzi,M., Gardiman,M. P., Eoli,M., Rudà ,R., Brandes,A. A., Ibrahim,T., Rizzato,S., Lolli,I., Zagonel Vittorina, Lombardi GiuseppeClinical Cancer Research
Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic CancerMerz,V., Zecchetto,C., Santoro,R., Simionato,F., Sabbadini,F., Mangiameli,D., Piro,G., Cavaliere,A., Deiana,M., Valenti,M. T., Bazan,D., Fedele,V., Lonardi Sara, Melisi,D.Clinical Cancer Research
Serum alpha-fetoprotein levels and clinical outcome in the phase 3 CELESTIAL study of cabozantinib versus placebo in patients with advanced hepatocellular carcinomaKelley,R. K., Meyer,T., Rimassa,L., Merle,P., Park,J. W., Yau,T., Chan,S. L., Blanc,J. F., Tam,V. C., Tran,A., Dadduzio Vincenzo, Markby,D. W., Kaldate,R., Cheng,A. L., El-Khoueiry,A. B., Abou-Alfa,G. K.Clinical Cancer Research
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular CarcinomaKelley,R. K., Meyer,T., Rimassa,L., Merle,P., Park,J. W., Yau,T., Chan,S. L., Blanc,J. F., Tam,V. C., Tran,A., Dadduzio Vincenzo, Markby,D. W., Kaldate,R., Cheng,A. L., El-Khoueiry,A. B., Abou-Alfa,G. K.Clinical Cancer Research
Genetic, Epigenetic, and Immunologic Profiling of MMR-Deficient Relapsed GlioblastomaIndraccolo Stefano, Lombardi Giuseppe, Fassan,M., Pasqualini, L, Giunco, S, Marcato Raffaella, Gasparini, A, Candiotto Cinzia, Nalio Silvia, Fiduccia Pasquale, Fanelli,G. N., Pambuku Ardi, Della Puppa,A., D'Avella,D., Bonaldi Laura, Gardiman,M. P., Bertorelle Roberta, De Rossi Anita, Zagonel VittorinaClinical Cancer Research
KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target PopulationSchirripa Marta, Nappo,F., Cremolini,C., Salvatore,L., Rossini,D., Bensi,M., Businello,G., Pietrantonio,F., Randon,G., Fucà ,G., Boccaccino,A., Bergamo Francesca, Lonardi Sara, Dei Tos,A. P., Fassan,M., Loupakis FotiosClinical Colorectal Cancer
Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients: A Multi-institutional AnalysisRossini,D., Germani,M. M., Pagani,F., Pellino,A., Dell'Aquila,E., Bensi,M., Liscia,N., Moretto,R., Boccaccino,A., Prisciandaro,M., Manglaviti,S., Schirripa Marta, Vivolo,R., Scartozzi,M., Santini,D., Salvatore,L., Pietrantonio,F., Loupakis Fotios, Falcone,A., Cremolini,C. (...)Clinical Colorectal Cancer
Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective StudyVitale,M. G., Pipitone,S., Venturelli,M., Baldessari,C., Porta,C., Iannuzzi,F., Basso Umberto, Scagliarini,S., Zucali,P. A., Galli,L., Rossetti,S., Caserta,C., Bracarda,S., Iacovelli,R., Masini,C., Cortellini,A., Di Girolamo,S., Buti,S., Fornarini,G., Carrozza,F. (...)Clinical genitourinary cancer
Trabectedin in Malignant Pleural Mesothelioma: Results From the Multicentre, Single Arm, Phase II ATREUS StudyCortinovis,D., Grosso,F., Carlucci,L., Zucali,P. A., Pasello Giulia, Tiseo,M., Sperandi,F., Hollander,L., Galli,F., Torri,V., Rulli,E., Canova,S., Maconi,A., Bidoli,P., Ceresoli,G. L., D'Incalci,M., ATREUS investigatorsClinical Lung Cancer
10-Year Clinical Experience With 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 PatientsZattoni,F., Ravelli,I., Rensi,M., Capobianco,D., Borsatti,E., Baresic,T., Chiaravalloti,A., Schillaci,O., Alongi,P., Bartolotta,T. V., Rambaldi,I., Bartolomei,M., Farsad,M., Tredici,M., Donner,D., Chierichetti,F., Trifirò,G., Brugola,E., Burei Marta, Dal Moro,F. (...)Clinical nuclear medicine
Re: A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CTEvangelista Laura, Sepulcri MatteoClinical nuclear medicine
Anaplastic Astrocytoma: State of the art and future directionsCaccese Mario, Padovan,M., D'Avella,D., Chioffi,F., Gardiman,M. P., Berti Franco, Busato,F., Bellu Luisa, Bergo Eleonora, Zoccarato,M., Fassan,M., Zagonel Vittorina, Lombardi GiuseppeCritical reviews in oncology/hematology
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelinesPassiglia,F., Bertolaccini,L., Del Re,M., Facchinetti,F., Ferrara,R., Franchina,T., Malapelle,U., Menis Jessica, Passaro,A., Pilotto,S., Ramella,S., Rossi,G., Trisolini,R., Novello,S.Critical reviews in oncology/hematology
Comparison between 18f-Dopa and 18f-Fet Pet/Ct in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and our ExperienceEvangelista Laura, Cuppari Lea, Bellu Luisa, Bertin Daniele, Caccese Mario, Reccia Pasquale, Zagonel Vittorina, Lombardi GiuseppeCurrent radiopharmaceuticals
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasksPalmerini,P., Dalla Pietà, A., Sommaggio Roberta, Ventura,A., Astori,G., Chieregato,K., Tisi,M. C., Visco,C., Perbellini,O., Ruggeri,M., Cappuzzello,E., Rosato AntonioCYTOTHERAPY
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY surveyPezzilli,R., Buscarini,E., Pollini,T., Bonamini,D., Marchegiani,G., Crippa,S., Belfiori,G., Sperti,C., Moletta,L., Pozza,G., De Nucci,G., Manes,G., Mandelli,E. D., Casadei,R., Ricci,C., Alicante,S., Vattiato,C., Carrara,S., Di Leo,M., Fabbri,C. (...)Digestive and Liver Disease
Reorganization of the endoscopic activity of Cancer Institutes during phase II of the Covid-19 emergencyGiancarla,F., Cristina,T., Teresa,S., Andrea,M., Vittoria,S., Enzo,M., Mario,C., Battista,R. G., Fantin Alberto, Realdon Stefano, Ippazio,U., Renato,C.Digestive and Liver Disease
Acute heart failure in parathyreotoxicosisBattistella,E., Pomba Luca, Toniato AntonioEndocrine
Colonoscopy related adverse events and mortality in an Italian organized colorectal cancer screening programBenazzato,L., Zorzi,M., Antonelli,G., Guzzinati,S., Hassan,C., Fantin AlbertoEndoscopy
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: Young oncologists' perspectiveLambertini,M., Toss,A., Passaro,A., Criscitiello,C., Cremolini,C., Cardone,C., Loupakis Fotios, Viscardi,G., Meattini,I., Dieci Maria Vittoria, Ferrara,R., Giusti,R., Maio,M. D.ESMO Open
Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: Results from an international, multi-institutional, retrospective analysisNapolitano,A., Provenzano,S., Colombo,C., Vitellaro,M., Brunello Antonella, Badalamenti,G., Nannini,M., Ibrahim,T., Hohenberger,P., Gasperoni,S., Gennatas,S., Jones,R. L., Hindi,N., Martin-Broto,J., Spalato Ceruso,M., Silletta,M., Dei Tos,A. P., Gronchi,A., Stacchiotti,S., Santini,D. (...)ESMO Open
LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trialVernieri,C., Ganzinelli,M., Rulli,E., Farina,G., Bettini,A. C., Bareggi,C., Rosso,L., Signorelli,D., Galli,G., Lo Russo,G., Proto,C., Moro,M., Indraccolo Stefano, Busico,A., Sozzi,G., Torri,V., Marabese,M., Massimo,B., Garassino,M. C., TAILOR trialists (...)ESMO Open
Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: A clinical and molecular proof of concept studyCremolini,C., Benelli,M., Fontana,E., Pagani,F., Rossini,D., Fucà,G., Busico,A., Conca,E., Di Donato,S., Loupakis Fotios, Schirripa Marta, Lonardi Sara, Borelli,B., Ongaro,E., Eason,K., Morano,F., Casagrande,M., Fassan,M., Sadanandam,A., De Braud,F. (...)ESMO Open
A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trialsBerger,M. D., Ning,Y., Stintzing,S., Heinemann,V., Cao,S., Zhang,W., Yang,D., Miyamoto,Y., Suenaga,M., Schirripa Marta, Hanna,D. L., Soni,S., Puccini,A., Tokunaga,R., Naseem,M., Battaglin,F., Cremolini,C., Falcone,A., Loupakis Fotios, Lenz,H. -J (...)European Journal of Cancer
Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiativeCohen,R., Vernerey,D., Bellera,C., Meurisse,A., Henriques,J., Paoletti,X., Rousseau,B., Alberts,S., Aparicio,T., Boukovinas,I., Gill,S., Goldberg,R. M., Grothey,A., Hamaguchi,T., Iveson,T., Kerr,R., Labianca,R., Lonardi Sara, Meyerhardt,J., Paul,J. (...)European Journal of Cancer
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino studyRaimondi,A., Di Maio,M., Morano,F., Corallo,S., Lonardi Sara, Antoniotti,C., Rimassa,L., Sartore-Bianchi,A., Tampellini,M., Ritorto,G., Murialdo,R., Clavarezza,M., Zaniboni,A., Adamo,V., Tomasello,G., Petrelli,F., Antonuzzo,L., Giordano,M., Cinieri,S., Longarini,R. (...)European Journal of Cancer
Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG)Casanova,M., Brennan,B., Alaggio,R., Kelsey,A., Orbach,D., van Noesel,M. M., Corradini,N., Minard-Colin,V., Zanetti,I., Bisogno,G., Gallego,S., Merks,J. H. M., De Salvo Gian Luca, Ferrari,A.European Journal of Cancer
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapyDieci Maria Vittoria, Tsvetkova,V., Griguolo Gaia, Miglietta,F., Tasca Giulia, Giorgi Carlo Alberto, Cumerlato,E., Massa,D., Lo Mele,M., Orvieto,E., Guarneri Valentina, Conte PierFrancoEuropean Journal of Cancer
Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapyFerrari,A., Merks,J. H. M., Chisholm,J. C., Orbach,D., Brennan,B., Gallego,S., van Noesel,M. M., McHugh,K., van Rijn,R. R., Gaze,M. N., Martelli,H., Bergeron,C., Corradini,N., Minard-Colin,V., Bisogno,G., Geoerger,B., Caron,H. N., De Salvo Gian Luca, Casanova,M.European Journal of Cancer
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trialsMoretto,R., Corallo,S., Belfiore,A., Rossini,D., Boccaccino,A., Lonardi Sara, Centonze,G., Morano,F., Germani,M. M., Loupakis Fotios, Morelli,L., Urbani,L., Brich,S., Marmorino,F., Prisciandaro,M., Aprile,G., Fassan,M., Cillo,U., Cattaneo,L., Fontanini,G. (...)European Journal of Cancer
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trialPasqualetti,G., Schirripa Marta, Dochy,E., Fassan,M., Ziranu,P., Puzzoni,M., Scartozzi,M., Alberti,G., Lonardi Sara, Zagonel Vittorina, Monzani,F., Loupakis FotiosEuropean Journal of Cancer
Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)Mandalà ,M., Galli,F., Patuzzo,R., Maurichi,A., Mocellin Simone, Rossi Carlo Riccardo, Rulli,E., Montesco,M., Quaglino,P., Caliendo,V., De Giorgi,V., Merelli,B., Caracò,C., Piazzalunga,D., Labianca,A., Ribero,S., Senetta,R., Gianatti,A., Valeri,B., Massi,D. (...)European Journal of Cancer
Bioinspired hyaluronic acid and polyarginine nanoparticles for DACHPt deliveryMatha,K., Lollo,G., Taurino,G., Respaud,R., Marigo Ilaria , Shariati,M., Bussolati,O., Vermeulen,A., Remaut,K., Benoit,J. -PEUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Accuracy of mammography dosimetry in the era of the European Directive 2013/59/Euratom transpositionGennaro Gisella Maria, Bigolaro,S., Hill,M. L., Stramare,R., Caumo FrancescaEuropean Journal of Radiology
Lesions of uncertain malignant potential of the breast (B3) on vacuum-assisted biopsy for microcalcifications: Predictors of malignancyMariscotti,G., Durando,M., Ruggirello,I., Belli,P., Caumo Francesca, Nori,J., Zuiani,C., Tagliafico,A., Bicchierai,G., Romanucci,G., Londero,V., Campanino,P. P., Bussone,R., Castellano,I., Mule,A., Caneva,A., Bianchi,S., Di Loreto,C., Bergamasco,L., Calabrese,M. (...)European Journal of Radiology
Analysis of morbidity and mortality, quality of life and bowel function after total colectomy with ileorectal anastomosis versus right and left hemicolectomy: A study to optimise the treatment of lynch syndrome and attenuated polyposis coliUrso,E. D. L., Celotto,F., Giandomenico,F., Gavaruzzi,T., Del Bianco Paola, Lotto,L., Spolverato,G., Pucciarelli,S., Bao,Q. R.European Journal of Surgical Oncology
Differences in direct costs of patients with stage I cutaneous melanoma: A real-world data analysisBuja,A., Rivera,M., De Polo,A., Zorzi,M., Baracco,M., Italiano,I., Vecchiato Antonella, Del Fiore Santo Paolo, Guzzinati,S., Saia,M., Baldo,V., Rugge,M., Rossi Carlo RiccardoEuropean Journal of Surgical Oncology
Past, present and future of adjuvant HIPEC in patients at high risk for colorectal peritoneal metastasesBaratti,D., Sammartino,P., Kusamura,S., Deraco,M., Peritoneal Surface Malignancy Onco-team of the Ita, Ansaloni,L., Asero,S., Baiocchi,G., Bagnoli,P., Cavaliere,D., Framarini,M., Cirocchi,R., Coccolini,F., Decian,F., Delrio,P., Sassaroli,C., De Simone,M., Robella,M., Vaira,M., Di Giorgio,A. (...)European Journal of Surgical Oncology
The sacral chordoma marginRadaelli,S., Fossati,P., Stacchiotti,S., Akiyama,T., Asencio,J.M., Bandiera,S., Boglione,A., Boland,P., Bolle,S., Bruland,O., Brunello Antonella, Bruzzi,P., Campanacci,D., Cananzi,F., Capanna,R., Casadei,R., Cordoba,A., Court,C., Dei Tos,A.P., DeLaney,T.F. (...)European Journal of Surgical Oncology
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trialMeessen,J. M. T. A., Cardinale,D., Ciceri,F., Sandri,M. T., Civelli,M., Bottazzi,B., Cucchi,G., Menatti,E., Mangiavacchi,M., Condorelli,G., Barbieri,E., Gori,S., Colombo,A., Curigliano,G., Salvatici,M., Pastori,P., Ghisoni,F., Bianchi Alessandra, Falci Cristina, Cortesi,P. (...)European Society of Cardiology Heart Failure Association
Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?Novara,G., Checcucci,E., CRESTANI ALESSANDRO, Abrate,A., Esperto,F., Pavan,N., De Nunzio,C., Galfano,A., Giannarini,G., Gregori,A., Liguori,G., Bartoletti,R., Porpiglia,F., Scarpa,R. M., Simonato,A., Trombetta,C., Tubaro,A., Ficarra,V., Research Urology Network (RUN)European Urology
A Contemporary Case Series of Complex Surgical Repair of Surgical/Endoscopic Injuries to the Abdominal UreterFicarra,V., Rossanese,M., CRESTANI ALESSANDRO, Caloggero,S., Alario,G., Novara,G., Giannarini,G., Valotto,C.European urology focus
Risk of Virus Contamination Through Surgical Smoke During Minimally Invasive Surgery: A Systematic Review of Literature on a Neglected Issue Revived in the COVID-19 Pandemic EraPavan,N., CRESTANI ALESSANDRO, Abrate,A., Nunzio,C., Esperto,F., Giannarini,G., Galfano,A., Gregori,A., Liguori,G., Bartoletti,R., Porpiglia,F., Simonato,A., Trombetta,C., Tubaro,A., Ficarra,V., Novara,G., Research Urology Network (RUN)European urology focus
The Role of Radiolabeled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for the Evaluation of Renal CancerEvangelista Laura, Basso Umberto, Maruzzo Marco, Novara,G.European urology focus
Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208-16Evangelista,L., De Salvo Gian Luca, Zattoni,F., Novara,G.European urology oncology
Targeting the cutaneous lymphocyte antigen (CLA) in inflammatory and neoplastic skin conditionsSernicola,A., Russo,I., Silic-Benussi Micol, Ciminale Vincenzo, Alaibac,M.Expert Opinion on Biological Therapy
Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectivesSartori,G., Belluomini,L., Lombardo,F., Avancini,A., Trestini,I., Vita,E., Tregnago,D., Menis Jessica, Bria,E., Milella,M., Pilotto,S.Expert Review of Anticancer Therapy
Use of antibiotic prophylaxis is not needed for endoscopic ultrasound-guided fine needle aspiration of pancreatic cysts: a meta-analysisFacciorusso,A., Mohan,B. P., Tacelli,M., Crinò,S. F., Antonini,F., Fantin Alberto, Barresi,L.Expert Review of Gastroenterology & Hepatology
COVID-19: ensuring our medical equipment can meet the challengeGarzotto Francesco, Ceresola,E., Panagiotakopoulou Sofia, Spina,G., Menotto,F., Benozzi,M., Casarotto,M., Lanera,C., Bonavina Maria Giuseppina, Gregori,D., Meneghesso,G., Opocher GiuseppeExpert review of medical devices
A Novel MAX Gene Mutation Variant in a Patient With Multiple and 'Composite' Neuroendocrine-Neuroblastic TumorsPozza,C., Sesti,F., Di Dato,C., Sbardella,E., Pofi,R., Schiavi Francesca, Bonifacio,V., Isidori,A. M., Faggiano,A., Lenzi,A., Giannetta,E.Frontiers in endocrinology
Helicobacter pylori Dampens HLA-II Expression on Macrophages via the Up-Regulation of miRNAs Targeting CIITACodolo,G., Toffoletto,M., Chemello,F., Coletta,S., Soler Teixidor,G., Battaggia,G., Munari Giada, Fassan,M., Cagnin,S., de Bernard,M.Frontiers in immunology
Myeloid Cells as Clinical Biomarkers for Immune Checkpoint BlockadePeranzoni,E., Ingangi Vincenzo, Masetto Elena, Pinton Laura, Marigo Ilaria Frontiers in immunology
A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma PatientsRastrelli Marco, Del Fiore Santo Paolo, Buja,A., Vecchiato Antonella, Rossi Carlo Riccardo, Chiarion-Sileni Vanna, Tropea Saveria, Russano Francesco, Zorzi,M., Spina Romina, Cappellesso,R., Mazzarotto,R., Cavallin,F., Bassetto,F., Bezzon,E., Ferrazzi,B., Alaibac,M., Mocellin SimoneFrontiers in Oncology
Extraskeletal Myxoid Chondrosarcoma: Clinical and Molecular Characteristics and Outcomes of Patients Treated at Two InstitutionsChiusole Benedetta, Le Cesne,A., Rastrelli Marco, Maruzzo Marco, Lorenzi,M., Cappellesso,R., Del Fiore Santo Paolo, Imbevaro Silvia, Sbaraglia,M., Terrier,P., Ruggieri,P., Dei Tos,A. P., Rossi Carlo Riccardo, Zagonel Vittorina, Brunello AntonellaFrontiers in Oncology
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working GroupRacanelli,D., Brenca,M., Baldazzi,D., Goeman,F., Casini,B., De Angelis,B., Guercio,M., Milano,G. M., Tamborini,E., Busico,A., Dagrada,G., Garofalo Cecilia, Caruso Chiara, Brunello Antonella, Pignochino,Y., Berrino,E., Grignani,G., Scotlandi,K., Parra,A., Hattinger,C. M. (...)Frontiers in Oncology
Pharmacogenomics Biomarkers of Soft Tissue Sarcoma TherapiesCaruso Chiara, Garofalo CeciliaFrontiers in Oncology
Rare Primary Central Nervous System Tumors in Adults: An OverviewFranceschi,E., Frappaz,D., Rudà,R., Hau,P., Preusser,M., Houillier,C., Lombardi Giuseppe, Asioli,S., Dehais,C., Bielle,F., Di Nunno,V., van den Bent,M., Brandes,A. A., Idbaih,A., EURACAN Domain 10Frontiers in Oncology
The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and RealityFerrari,D., Ghi Maria Grazia, Franzese,C., Codecà ,C., Gau,M., Fayette,J.Frontiers in Oncology
Reflectance Confocal Microscopy in Evaluating Skin Cancer: A Clinicians's PerspectiveFiloni Angela, Alaibac,M.Frontiers in Oncology
Olaparib for advanced breast cancerGriguolo Gaia, Dieci Maria Vittoria, Miglietta,F., Guarneri Valentina, Conte PierFrancoFuture Oncology
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumabRuzzo,A., Graziano,F., Bagaloni,I., Di Bartolomeo,M., Prisciandaro,M., Aprile,G., Ongaro,E., Vincenzi,B., Perrone,G., Santini,D., Fornaro,L., Vivaldi,C., Tomasello,G., Loupakis Fotios, Lonardi Sara, Fassan,M., Valmasoni,M., Sarti,D., Lorenzini,P., Catalano,V. (...)Gastric Cancer
Impact of Age on Short- And Long-Term Outcomes after Pancreatoduodenectomy for Periampullary NeoplasmsGruppo Mario, Tolin Francesca , Franzato Boris, Pilati Pierluigi, Spolverato,Y. C., Zingales,F., Angriman,I., Bardini,R.Gastroenterology Research and Practice
Transcriptome-wide association study of breast cancer risk by estrogen-receptor statusFeng,H., Gusev,A., Pasaniuc,B., Wu,L., Long,J., Abu-full,Z., Aittomäki,K., Andrulis,I. L., Anton-Culver,H., Antoniou,A. C., Arason,A., Arndt,V., Aronson,K. J., Arun,B. K., Asseryanis,E., Auer,P. L., Azzollini,J., Balmaña,J., Barkardottir,R. B., Barnes,D. R. (...)Genetic Epidemiology
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variantsBarnes,D. R., Rookus,M. A., McGuffog,L., Leslie,G., Mooij,T. M., Dennis,J., Mavaddat,N., Adlard,J., Ahmed,M., Aittomäki,K., Andrieu,N., Andrulis,I. L., Arnold,N., Arun,B. K., Azzollini,J., Balmaña,J., Barkardottir,R. B., Barrowdale,D., Benitez,J., Berthet,P. (...)Genetics in Medicine
Abnormal liver function tests in COVID-19 patients: relevance and potential pathogenesisBertolini,A., van de Peppel,I. P., Bodewes,F. A. J. A., Moshage,H., Fantin Alberto, Farinati,F., Fiorotto,R., Jonker,J. W., Strazzabosco,M., Verkade,H. J., Peserico GiuliaHepatology
Immunohistochemical neuroendocrine marker expression in primary pulmonary NUT carcinoma: a diagnostic pitfallPezzuto,F., Fortarezza,F., Mammana,M., Pasello Giulia, Pelosi,G., Rea,F., Calabrese,F.Histopathology
Evolving use of liquid biopsy in non-small-cell-lung cancer patientsIndraccolo StefanoInternational Journal of Biological Markers
Molecular imaging and immunotherapyEvangelista LauraInternational Journal of Biological Markers
State of the art and trends of circulating cancer biomarkersGion,M., Trevisiol Chiara, Fabricio,A. S. C.International Journal of Biological Markers
Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screeningCuzick,J., Adcock,R., Carozzi,F., Gillio-Tos,A., De Marco,L., Del Mistro Annarosa, Frayle - Salamanca Helena, Girlando,S., Sani,C., Confortini,M., Zorzi,M., Giorgi-Rossi,P., Rizzolo,R., Ronco,G., the New Technologies for Cervical Cancer ScreeningInternational Journal of Cancer
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancerNeuzillet,C., Casadei-Gardini,A., Brieau,B., Vivaldi,C., Brandi,G., Tougeron,D., Filippi,R., Vienot,A., Silvestris,N., Pointet,A. L., Lonardi Sara, Rousseau,B., Scartozzi,M., Dahan,L., Aprile,G., Le Sourd,S., Evesque,L., Meurisse,A., Lièvre,A., Vernerey,D. (...)International Journal of Cancer
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasisSchlicker,A., Ellappalayam,A., Beumer,I. J., Snel,M. H. J., Mittempergher,L., Diosdado,B., Dreezen,C., Tian,S., Salazar,R., Loupakis Fotios, Pietrantonio,F., Santos Vivas,C., Martinez-Villacampa,M. M., Villanueva,A., Sanjuàn,X., Schirripa Marta, Fassan,M., Martinetti,A., Fucà ,G., Lonardi Sara (...)International Journal of Cancer
Selenium Supplementation, Body Mass Composition, and Leptin Levels in Patients with Obesity on a Balanced Mildly Hypocaloric Diet: A Pilot StudyCavedon Elisabetta, Manso,J., Negro,I., Censi,S., Serra,R., Busetto,L., Vettor,R., Plebani,M., Pezzani,R., Nacamulli,D., Mian,C.International Journal of Endocrinology
Extent of primary DNA damage measured by the comet assay in health professionals exposed to antineoplastic drugs: A systematic review and meta-analysisGianfredi,V., Nucci Daniele, Fatigoni,C., Salvatori,T., Villarini,M., Moretti,M.International Journal of Environmental Research and Public Health
Detection of LINE-1 hypomethylation in cfDNA of Esophageal Adenocarcinoma PatientsBoldrin Daniela, Curtarello Matteo, Dallan,M., Alfieri Rita, Realdon Stefano, Fassan,M., Saggioro DanielaInternational Journal of Molecular Sciences
Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for TreatmentFrega Stefano, Ferro,A., Bonanno Laura, Guarneri Valentina, Conte PierFranco, Pasello GiuliaInternational Journal of Molecular Sciences
Evaluating nephrocheck as a predictive tool for acute kidney injuryNalesso,F., Cattarin,L., Gobbi,L., Fragasso,A., Garzotto Francesco, Calò,L. A.International journal of nephrology and renovascular disease
Testosterone is sequestered in dysfunctional adipose tissue, modifying androgen-responsive genesDi Nisio,A., Sabovic,I., De Toni,L., Rocca Maria Santa, Dall'Acqua,S., Azzena,B., De Rocco Ponce,M., Foresta,C.International Journal of Obesity
Comparison of Pheochromocytoma-Specific Morbidity and Mortality among Adults with Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing AdrenalectomyNeumann,H. P. H., Tsoy,U., Bancos,I., Amodru,V., Walz,M. K., Tirosh,A., Kaur,R. J., McKenzie,T., Qi,X., Bandgar,T., Petrov,R., Yukina,M. Y., Roslyakova,A., Van Der Horst-Schrivers,A. N. A., Berends,A. M. A., Hoff,A. O., Castroneves,L. A., Ferrara Alfonso Massimiliano, Rizzati Silvia, Mian,C. (...)JAMA network open
Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical TrialPetrelli,F., Labianca,R., Zaniboni,A., Lonardi Sara, Galli,F., Rulli,E., Rosati,G., Corallo,S., Ronzoni,M., Cardellino,G. G., Mattioli,R., Mambrini,A., Ciuffreda,L., Banzi,M., Pusceddu,V., Maiello,E., Zampino,M., Zagonel Vittorina, Marchetti,P., Corsi,D. (...)JAMA ONCOLOGY
Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer: Long-term Results of Treatment With Trastuzumab and LapatinibSartore-Bianchi,A., Lonardi Sara, Aglietta,M., Martino,C., Ciardiello,F., Marsoni,S., Siena,S.JAMA ONCOLOGY
Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Silvestri,V., Leslie,G., Barnes,D. R., and the CIMBA Group, Agnarsson,B. A., Aittomäki,K., Alducci Elisa, Andrulis,I. L., Barkardottir,R. B., Barroso,A., Barrowdale,D., Benitez,J., Bonanni,B., Borg,A., Buys,S. S., Caldés,T., Caligo,M. A., Capalbo,C., Campbell,I., Chung,W. K. (...)JAMA ONCOLOGY
Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast CancerVaidya,J. S., Bulsara,M., Saunders,C., Flyger,H., Tobias,J. S., Corica,T., Massarut,S., Wenz,F., Pigorsch,S., Alvarado,M., Douek,M., Eiermann,W., Brew-Graves,C., Williams,N., Potyka,I., Roberts,N., Bernstein,M., Brown,D., Sperk,E., Laws,S. (...)JAMA ONCOLOGY
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanomaAscierto,P. A., Del Vecchio,M., Mackiewicz,A., Robert,C., Chiarion-Sileni Vanna, Arance,A., Lebbé,C., Svane,I. M., Mcneil,C., Rutkowski,P., Loquai,C., Mortier,L., Hamid,O., Bastholt,L., Dreno,B., Schadendorf,D., Garbe,C., Nyakas,M., Grob,J. -J, Thomas,L. (...)Journal for immunotherapy of cancer
Limiting treatment plan complexity by applying a novel commercial toolScaggion Alessandro, Fusella Marco, Agnello,G., Bettinelli Andrea, Pivato,N., Roggio Antonella, Rossato Marco Andrea, Sepulcri Matteo, Paiusco MartaJournal of applied clinical medical physics
TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinomaBoscolo-Rizzo,P., Giunco,S., Rampazzo,E., Brutti Martina, Spinato,G., Menegaldo,A., Stellin,M., Mantovani,M., Bandolin,L., Rossi,M., Del Mistro Annarosa, Tirelli,G., Dei Tos,A. P., Guerriero,A., Niero,M., Da Mosto,M. C., Polesel,J., De Rossi AnitaJournal of cancer research and clinical oncology
A Continuous Renal Replacement Therapy Protocol for Patients with Acute Kidney Injury in Intensive Care Unit with COVID-19Nalesso,F., Garzotto Francesco, Cattarin,L., Gobbi,L., Qassim,L., Sgarabotto,L., Tiberio,I., Calò. A.Journal of clinical medicine
Comparison of the Genomic Profile of Cancer Stem Cells and Their Non-Stem Counterpart: The Case of Ovarian CancerMazzoldi Elena Laura, Pastò,A., Pilotto Giorgia, Minuzzo,S., Piga,I., Palumbo,P., Carella,M., Frezzini,S., Nicoletto Maria Ornella, Amadori Alberto, Indraccolo StefanoJournal of clinical medicine
Macular Perfusion Impairment in Von Hippel-Lindau Disease Suggests a Generalized Retinal Vessel AlterationPilotto,E., Nacci,E. B., Ferrara Alfonso Massimiliano, De Mojà ,G., Zovato Stefania, Midena,E.Journal of clinical medicine
Nintedanib Treatment for Idiopathic Pulmonary Fibrosis Patients Who Have Been Switched from Pirfenidone Therapy: A Retrospective Case Series StudyVianello,A., Salton,F., Molena,B., Turato Cristian, Graziani,M. L., Braccioni,F., Frassani,V., Sella,D., Pretto,P., Paladini,L., Sukthi,A., Confalonieri,M.Journal of clinical medicine
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma GroupsGronchi,A., Palmerini,E., Quagliuolo,V., Martin Broto,J., Lopez Pousa,A., Grignani,G., Brunello Antonella, Blay,J. Y., Tendero,O., Diaz Beveridge,R., Ferraresi,V., Lugowska,I., Merlo,D. F., Fontana,V., Marchesi,E., Braglia,L., Donati,D. M., Palassini,E., Bianchi,G., Marrari,A. (...)Journal of Clinical Oncology
Poly(L-glutamic acid)-co-poly(ethylene glycol) block copolymers for protein conjugationMaso,K., Grigoletto,A., Raccagni,L., Bellini,M., Marigo Ilaria , Ingangi Vincenzo, Suzuki,A., Hirai,M., Kamiya,M., Yoshioka,H., Pasut,G.Journal of Controlled Release
Metastases to the thyroid gland: review of incidence, clinical presentation, diagnostic problems and surgery, our experienceBattistella,E., Pomba Luca, Mattara Genny, Franzato Boris, Toniato AntonioJournal of endocrinological investigation
A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave?Silvestris,N., Apolone,G., Botti,G., Ciliberto,G., Costantini,M., De Paoli,P., Franceschi,S., Opocher Giuseppe, Paradiso,A., Pronzato,P., Sgambato,A., De Maria,R.Journal of Experimental & Clinical Cancer Research
Non-Operative Management Versus Total Mesorectal Excision for Locally Advanced Rectal Cancer with Clinical Complete Response After Neoadjuvant Chemoradiotherapy: a GRADE Approach by the Rectal Cancer Guidelines Writing Group of the Italian Association of Medical Oncology (AIOM)Capelli,G., De Simone,I., Spolverato,G., Cinquini,M., Moschetti,I., Lonardi Sara, Masi,G., Carlomagno,C., Corsi,D., Luppi,G., Gambacorta,M. A., Valvo,F., Cannizzaro,R., Grillo,F., Barbaro,B., Restivo,A., Messina,M., Pastorino,A., Aschele,C., Pucciarelli,S. (...)Journal of Gastrointestinal Surgery
Anti-PD1 antibodies in patients aged ? 75 years with metastatic melanoma: A retrospective multicentre studyRidolfi,L., De Rosa,F., Petracci,E., Tanda,E. T., Marra,E., Pigozzo Jacopo, Marconcini,R., Guida,M., Cappellini,G. C. A., Gallizzi,G., Occelli,M., Pala,L., Gambale,E., Bersanelli,M., Galdo,G., Cortellini,A., Morgese,F., Zoratto,F., Stucci,L. S., Strippoli,S. (...)Journal of Geriatric Oncology
Biological Aging and Immune Senescence in Children with Perinatally Acquired HIVDalzini,A., Petrara,M. R., Ballin,G., Zanchetta Marisa, Giaquinto,C., De Rossi AnitaJournal of Immunology Research
Mathematical models for HIV treatment : A schematic reviewBuratto,A., Cesaretto,R., Zamarchi RitaJournal of Interdisciplinary Mathematics
Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsulesPinton Laura, Magri,S., Masetto Elena, Vettore,M., Schibuola,I., Ingangi Vincenzo, Marigo Ilaria , Matha,K., Benoit,J. -P, Della Puppa,A., Bronte,V., Lollo,G., Mandruzzato SusannaJournal of Nanobiotechnology
Italian consensus and recommendations on diagnosis and treatment of low-grade gliomas. An intersocieties (SINch/AINO/SIN) documentRudà,R., Angileri,F. F., Ius,T., Silvani,A., Sarubbo,S., Solari,A., Castellano,A., Falini,A., Pollo,B., Del Basso De Caro,M., Papagno,C., Minniti,G., De Paula,U., Navarria,P., Nicolato,A., Salmaggi,A., Pace,A., Fabi,A., Caffo,M., Lombardi Giuseppe (...)Journal of neurosurgical sciences
Von Hippel-Lindau disease and multispecialist teamPavesi,G., Feletti,A., Ferrara Alfonso Massimiliano, Anglani,M., Scarpa,B., Schiavi Francesca, Boaretto Francesca, Zovato Stefania, Taschin Elisa, Gardi,M., Zanoletti,E., Piermarocchi,S., Murgia,A., Opocher Giuseppe, VHL-Padova NetworkJournal of neurosurgical sciences
The path to a better biomarker: Application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practiceGonzalez-Ericsson,P., Stovgaard,E. S., Sua,L. F., Reisenbichler,E., Kos,Z., Carter,J. M., Michiels,S., Le Quesne,J., Nielsen,T. O., Lænkholm,A. -V, Fox,S. B., Adam,J., Bartlett,J. M. S., Rimm,D. L., Quinn,C., Peeters,D., Dieci Maria Vittoria, Vincent-Salomon,A., Cree,I., Hida,A. I. (...)Journal of Pathology
Synthesis and preclinical evaluation of the 99mTc-/177Lu-CXCR4-L theranostic pair for in vivo chemokine-4 receptor-specific targetingÁvila-Sánchez,M., Ferro-Flores,G., Jiménez-Mancilla,N., Ocampo-Garcìa,B., Bravo-Villegas,G., Luna-Gutierrez,M., Santos-Cuevas,C., Azorì­n-Vega,E., Aranda-Lara,L., Isaac-Olivè,K., Melendez-Alafort LauraJournal of Radioanalytical and Nuclear Chemistry
MC1R variants in relation to naevi in melanoma cases and controls: a pooled-analysis from the M-SKIP projectStefanaki,I., Stratigos,A. J., Kypreou,K. P., Evangelou,E., Gandini,S., Maisonneuve,P., Polsky,D., Lazovich,D., Newton-Bishop,J., Kanetsky,P. A., Puig,S., Gruis,N. A., Ghiorzo,P., Pellegrini,C., De Nicolo Arcangela, Ribas,G., Guida,G., Garcia-Borron,J. C., Fargnoli,M. C., Nan,H. (...)Journal of the European Academy of Dermatology and Venereology
Overall survival of CDK4/6-inhibitors-based treatments in clinically relevant subgroups of metastatic breast cancer: systematic review and meta-analysisSchettini,F., Giudici,F., Giuliano,M., Cristofanilli,M., Arpino,G., Del Mastro,L., Puglisi,F., De Placido,S., Paris,I., De Placido,P., Venturini,S., De Laurentis,M., Conte PierFranco, Juric,D., Llombart-Cussac,A., Pusztai,L., Prat,A., Jerusalem,G., Di Leo,A., Generali,D. (...)Journal of the National Cancer Institute
p16/ki67 and E6/E7 mRNA accuracy and prognostic value in triaging HPV DNA-positive womenRossi,P. G., Carozzi,F., Ronco,G., Allia,E., Bisanzi,S., Gillio-Tos,A., De Marco,L., Rizzolo,R., Gustinucci,D., Del Mistro Annarosa, Frayle - Salamanca Helena, Confortini,M., Iossa,A., Cesarini,E., Bulletti,S., Passamonti,B., GORI SILVIA, Toniolo,L., Barca,A., Bonvicini,L. (...)Journal of the National Cancer Institute
Possible role of circulating tumor cells in early detection of lung cancerPoggiana Cristina, Poggiana Cristina, Zamarchi RitaJournal of Thoracic Disease
Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718QSong,Y., Jia,Z., Wang,Y., Wang,Y., Liu,P., Zhang,S., Bing,Z., Cao,L., Cao,Z., Rossi Elisabetta, Zamarchi Rita, Denis,M. G., Camps,C., Fernandez-Diaz,A., Liang,N., Li,S.Journal of Thoracic Disease
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR TrialPeters,S., Danson,S., Hasan,B., Dafni,U., Reinmuth,N., Majem,M., Tournoy,K. G., Mark,M. T., Pless,M., Cobo,M., Rodriguez-Abreu,D., Falchero,L., Moran,T., Ortega Granados,A. L., Monnet,I., Mohorcic,K., Sureda,B. M., Betticher,D., Demedts,I., Macias,J. A. (...)Journal of thoracic oncology
Checkpoint Inhibitors in SCLC: How Much Can We Trust in Randomized Cohorts of Phase I/II Trials?Menis Jessica, Reck,M.Journal of thoracic oncology
Combination of Immunotherapy and Radiotherapy - The Next Magic Step in the Management of Lung Cancer?Hendriks,L. E. L., Menis Jessica, De Ruysscher,D. K. M., Reck,M.Journal of thoracic oncology
E-Coaching: the DianaWeb study to prevent breast cancer recurrencesGianfredi,V., Nucci Daniele, Balzarini,M., Acito,M., Moretti,M., Villarini,A., Villarini,M.La Clinica terapeutica
Cancer and COVID-19: what do we really know?Poortmans,P. M., Guarneri Valentina, Cardoso,M. -JLancet
A new standard of care for patients with high-risk rhabdomyosarcoma? - Authors' replyBisogno,G., Ferrari,A., Melcon,S. G., De Salvo Gian Luca, Bergeron,C., Jenney,M.Lancet Oncology
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF(V600)-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trialDummer,R., Brase,J. C., Garrett,J., Campbell,C. D., Gasal,E., Squires,M., Gusenleitner,D., Santinami,M., Atkinson,V., Mandalà ,M., Chiarion-Sileni Vanna, Flaherty,K., Larkin,J., Robert,C., Kefford,R., Kirkwood,J. M., Hauschild,A., Schadendorf,D., Long,G. V.Lancet Oncology
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort studyGarassino,M. C., Whisenant,J. G., Huang,L. C., Trama,A., Torri,V., Agustoni,F., Baena,J., Banna,G., Berardi,R., Bettini,A. C., Bria,E., Brighenti,M., Cadranel,J., De Toma,A., Chini,C., Cortellini,A., Felip,E., Finocchiaro,G., Garrido,P., Genova,C. (...)Lancet Oncology
Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field studyKoller,M., Shamieh,O., Hjermstad,M. J., Hornslien,K., Young,T., Chalk,T., Ioannidis,G., Harle,A., Johnson,C. D., Tomaszewski,K. A., Serpentini Samantha, Pinto,M., van der Weijst,L., Janssens,A., Morag,O., Chie,W. C., Arraras,J. I., Pompili,C., Jungraithmayr,W., Hechtner,M. (...)Lancet Oncology
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trialCremolini,C., Antoniotti,C., Rossini,D., Lonardi Sara, Loupakis Fotios, Pietrantonio,F., Bordonaro,R., Latiano,T. P., Tamburini,E., Santini,D., Passardi,A., Marmorino,F., Grande,R., Aprile,G., Zaniboni,A., Murgioni Sabina, Granetto,C., Buonadonna,A., Moretto,R., Corallo,S. (...)Lancet Oncology
Cross-talk between GLI transcription factors and FOXC1 promotes T-cell acute lymphoblastic leukemia disseminationTosello Valeria, Bongiovanni,D., Liu,J., Pan,Q., Yan,K. K., Saccomani,V., Van Trimpont,M., Pizzi,M., Mazzoni,M., Dei Tos,A. P., Amadori Alberto, Zanovello Paola, Van Vlierberghe,P., Yu,J., Piovan ErichLeukemia
SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemiaGarcì­a-Canaveras,J. C., Lancho,O., Ducker,G. S., Ghergurovich,J. M., Xu,X., da Silva-Diz,V., Minuzzo,S., Indraccolo Stefano, Kim,H., Herranz,D., Rabinowitz,J. D.Leukemia
Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2Kudo,M., Galle,P. R., Llovet,J. M., Finn,R. S., Vogel,A., Motomura,K., Assenat,E., Merle,P., Brandi,G., Daniele,B., Okusaka,T., Tomasek,J., Borg,C., Dadduzio Vincenzo, Morimoto,M., Pracht,M., Jen,M. H., Drove Ubreva,N., Widau,R. C., Shinozaki,K. (...)Liver International
Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenibCasadei-Gardini,A., Dadduzio Vincenzo, Rovesti,G., Cabibbo,G., Vukotic,R., Rizzato,M. D., Orsi,G., Rossi,M., Guarneri,V., Lonardi Sara, D'agostino,D., Celsa,C., Andreone,P., Zagonel Vittorina, Scartozzi,M., Cascinu,S., Cucchetti,A.Medicine
Oesophageal perforation due to difficult intubation: our experience and review of literatureBattistella,E., Pomba Luca, Merigliano,S., Toniato AntonioMinerva chirurgica
Clinical pathways for urology patients during the COVID-19 pandemicSimonato,A., Giannarini,G., Abrate,A., Bartoletti,R., CRESTANI ALESSANDRO, De Nunzio,C., Gregori,A., Liguori,G., Novara,G., Pavan,N., Trombetta,C., Tubaro,A., Porpiglia,F., Ficarra,V., Research Urology Network (RUN)Minerva urologica e nefrologica
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study)Antonelli,A., Palumbo,C., Noale,M., Artibani,W., Bassi,P., Bertoni,F., Bracarda,S., Bruni,A., Corvò,R., Gacci,M., Magrini,S. M., Montironi,R., Porreca,A., Tubaro,A., Zagonel Vittorina, Maggi,S., and the Pros-IT CNR study groupMinerva urologica e nefrologica
Urology practice during the COVID-19 pandemicFicarra,V., Novara,G., Abrate,A., Bartoletti,R., CRESTANI ALESSANDRO, De Nunzio,C., Giannarini,G., Gregori,A., Liguori,G., Mirone,V., Pavan,N., Scarpa,R. M., Simonato,A., Trombetta,C., Tubaro,A., Porpiglia,F., Research Urology Network (RUN)Minerva urologica e nefrologica
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretomeCapaci,V., Bascetta,L., Fantuz,M., Beznoussenko,G. V., Sommaggio Roberta, Cancila,V., Bisso,A., Campaner,E., Mironov,A. A., Wiśniewski,J. R., Ulloa Severino,L., Scaini,D., Bossi,F., Lees,J., Alon,N., Brunga,L., Malkin,D., Piazza,S., Collavin,L., Rosato Antonio (...)Nature Communications
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockadeBrasó-Maristany,F., Griguolo Gaia, Pascual,T., Paré ,L., Nuciforo,P., Llombart-Cussac,A., Bermejo,B., Oliveira,M., Morales,S., Martì­nez,N., Vidal,M., Adamo,B., Martìnez,O., Pernas,S., Lòpez,R., Muñoz,M., Chic,N., Galvàn,P., Garau,I., Manso,L. (...)Nature Communications
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genesFachal,L., Aschard,H., Beesley,J., Barnes,D. R., Allen,J., Kar,S., Pooley,K. A., Dennis,J., Michailidou,K., Turman,C., Soucy,P., Lemaçon,A., Lush,M., Tyrer,J. P., Ghoussaini,M., Marjaneh,M. M., Jiang,X., Agata Simona, Aittomäki,K, Alonso,M. R. (...)Nature genetics
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibilityLandi,M. T., Bishop,D. T., MacGregor,S., Machiela,M. J., Stratigos,A. J., Ghiorzo,P., Brossard,M., Calista,D., Choi,J., Fargnoli,M. C., Zhang,T., Rodolfo,M., Trower,A. J., Menin,C., Martinez,J., Hadjisavvas,A., Song,L., Stefanaki,I., Scolyer,R., Yang,R. (...)Nature genetics
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analysesZhang,H., Ahearn,T. U., Lecarpentier,J., Barnes,D., Beesley,J., Qi,G., Jiang,X., O'Mara,T. A., Zhao,N., Bolla,M. K., Dunning,A. M., Dennis,J., Wang,Q., Ful,Z. A., Aittomäki,K., Andrulis,I. L., Anton-Culver,H., Arndt,V., Aronson,K. J., Arun,B. K. (...)Nature genetics
Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical propertiesPanciera,T., Citron,A., Di Biagio,D., Battilana,G., Gandin,A., Giulitti,S., Forcato,M., Bicciato,S., Panzetta,V., Fusco,S., Azzolin,L., Totaro,A., Dei Tos,A. P., Fassan,M., Vindigni,V., Bassetto,F., Rosato Antonio, Brusatin,G., Cordenonsi,M., Piccolo,S. (...)Nature Materials
Medulloblastoma of the adult: results from a multicenter retrospective study by AINO (Italian Association of Neuro-Oncology) and SIN (Italian Society of Neurology)Gaviani,P., Simonetti,G., Ruda,R., Franchino,F., Lombardi Giuseppe, Possanzini,M., Squintu,S., Villani,V., Teriaca,M., Cavallieri,F., Caffo,M., Salmaggi,A., Bianco,A., Anghileri,E., Farinotti,M., Tramacere,I., Silvani,A.Neurological Sciences
The Bruton tyrosine kinase inhibitor ibrutinib improves anti-MAG antibody polyneuropathyCastellani,F., Visentin,A., Campagnolo,M., Salvalaggio,A., Cacciavillani,M., Candiotto Cinzia, Bertorelle Roberta, Trentin,L., Briani,C.Neurology-Neuroimmunology & Neuroinflammation
A Molecular Signature associated with prolonged survival in Glioblastoma patients treated with RegorafenibSantangelo,A., Rossato,M., Lombardi Giuseppe, Benfatto,S., Lavezzari,D., De Salvo Gian Luca, Indraccolo Stefano, Dechecchi,M. C., Prandini,P., Gambari,R., Scapoli,C., Di Gennaro,G., Caccese Mario, Eoli,M., Rudà ,R., Brandes,A. A., Ibrahim,T., Rizzato,S., Lolli,I., Lippi,G. (...)Neuro-Oncology
Longitudinal evolution of the immune suppressive glioma microenvironment in different synchronous lesions during treatmentMandruzzato Susanna, Pinton Laura, Masetto Elena, Vettore,M., Bonaudo,C., Lombardi Giuseppe, Della Puppa,A.Neuro-oncology advances
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancerKos,Z., Roblin,E., Kim,R. S., Michiels,S., Gallas,B. D., Chen,W., van de Vijver,K. K., Goel,S., Adams,S., Demaria,S., Viale,G., Nielsen,T. O., Badve,S. S., Symmans,W. F., Sotiriou,C., Rimm,D. L., Hewitt,S., Denkert,C., Loibl,S., Luen,S. J. (...)NPJ breast cancer
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancerFiglioli,G., Bogliolo,M., Catucci,I., Caleca,L., Lasheras,S. V., Pujol,R., Kiiski,J. I., Muranen,T. A., Barnes,D. R., Dennis,J., Michailidou,K., Bolla,M. K., Leslie,G., Aalfs,C. M., Balleine,R., Baxter,R., Braye,S., Carpenter,J., Dahlstrom,J., Forbes,J. (...)NPJ breast cancer
Immune surveillance activation after neoadjuvant therapy for esophageal adenocarcinoma and complete responseKotsafti Andromachi, Scarpa Melania, Cavallin,F., Fassan,M., Salmaso,R., Porzionato,A., Saadeh,L., Cagol Matteo, Alfieri Rita, Castoro,C., Rugge,M., Castagliuolo,I., Scarpa,M.Oncoimmunology
Caring for Patients with Advanced Stage Cancer at the Time of COVID-19Brunello Antonella, Zagonel VittorinaOncologist
Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World ExperienceBonanno Laura, Pavan,A., Ferro,A., Calvetti,L., Frega Stefano, Pasello Giulia, Aprile,G., Guarneri Valentina, Conte PierFranco, Rete Oncologica Veneta (ROV)Oncologist
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease BurdenPietrantonio,F., Loupakis Fotios, Randon,G., Raimondi,A., Salati,M., Trapani,D., Pagani,F., Depretis Ilaria, Maddalena,G., Morano,F., Corallo,S., Prisciandaro,M., Corti,F., Guarini,V., Bocconi,A., Marra,A., Belli,C., Spallanzani,A., Fassan,M., Lonardi Sara (...)Oncologist
Management of germ cell tumors during the outbreak of the novel coronavirus disease-19 pandemic: a survey of international expertise centersNappi,L., Ottaviano,M., Rescigno,P., Tortora,M., Banna,G. L., Baciarello,G., Basso Umberto, Canil,C., Cavo,A., Rocca,M. C., Czaykowski,P., De Giorgi,U., Del Muro,X. G., Di Napoli,M., Fornarini,G., Gietema,J. A., Heng,D. Y. C., Hotte,S. J., Kollmannsberger,C., Maruzzo Marco (...)Oncologist
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating LymphocytesLoupakis Fotios, Depretis Ilaria, Biason Paola, Intini,R., Prete Alessandra Anna, Leone,F., Lombardi,P., Filippi,R., Spallanzani,A., Cascinu,S., Bonetti,L. R., Maddalena,G., Valeri,N., Sottoriva,A., Zapata,L., Salmaso,R., Munari Giada, Rugge,M., Dei Tos,A. P., Golovato,J. (...)Oncologist
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup AnalysisRosati,G., Galli,F., Cantore,M., Bergamo Francesca, Banzi,M., Zampino,M. G., Mattioli,R., Cardellino,G. G., Ronzoni,M., Di Bartolomeo,M., Tamberi,S., Marchetti,P., Rimassa,L., Corsi,D., Bochicchio,A. M., Artioli,F., Labianca,R., Galli,F., Rulli,E., Bilancia,D. (...)Oncologist
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast CancerMiglietta,F., Dieci Maria Vittoria, Tsvetkova,V., Griguolo Gaia, Vernaci,G., Menichetti,A., Faggioni Giovanni, Giarratano Tommaso, Mioranza Eleonora, Genovesi,E., Cumerlato,E., Bottosso,M., Saibene Tania, Michieletto Silvia, Lo Mele,M., Conte PierFranco, Guarneri ValentinaOncologist
Prognostic role of programmed death ligand 1 (PD-L1) and the immune microenvironment in laryngeal carcinomaAlessandrini,L., Franz,L., Ottaviano,G., Ghi Maria Grazia, Lanza,C., Blandamura,S., Marioni,G.Oral oncology
Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett's carcinogenesisFassan,M., Realdon Stefano, Cascione,L., Hahne,J. C., Munari Giada, Guzzardo,V., Arcidiacono Diletta, Lampis,A., Brignola,S., Dal Santo,L., Agostini,M., Bracon,C., Maddalo,G., Scarpa,M., Farinati,F., Zaninotto,G., Valeri,N., Rugge,M.Pathology, research and practice
Synchronous nodal metastatic risk in screening detected and endoscopically removed pT1 colorectal cancersCappellesso,R., Nicolè,L., Zanco,F., Lo Mele,M., Fassina,A., Ventura,L., Rosa-Rizzotto,E., Guido,E., De Lazzari,F., Pilati Pierluigi, Tonello Marco, Fassan,M., Rugge,M.Pathology, research and practice
Dermatofibrosarcoma protuberans in children and adolescents: The European Paediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005)Brennan,B., Zanetti,I., De Salvo Gian Luca, Orbach,D., Gallego,S., Francotte,N., Schifflers,S., Van Noesel,M., Kelsey,A., Casanova,M., Dagrada,G. P., Collini,P., Zin,A., Santoro,L., Ferrari,A.Pediatric Blood & Cancer
Paratesticular rhabdomyosarcoma-Impact of locoregional approach on patient outcome: A report from the European paediatric Soft tissue sarcoma Study Group (EpSSG)Rogers,T. N., De Corti,F., Burrieza,G. G., Guérin,F., Terwisscha van Scheltinga,S., Smeulders,N., Craigie,R., Jenney,M., Kelsey,A., Zanetti,I., Coppadoro,B., De Salvo Gian Luca, Bisogno,G., Martelli,H.Pediatric Blood & Cancer
Pheochromocytomas and paragangliomas in children: Data from the Italian Cooperative Study (TREP)Virgone,C., Andreetta,M., Avanzini,S., Chiaravalli,S., De Pasquale,D., Crocoli,A., Inserra,A., D'Angelo,P., Alaggio,R., Opocher Giuseppe, Cecchetto,G., Ferrari,A., Bisogno,G., Dall'Igna,P.Pediatric Blood & Cancer
Identification of host variants associated with overall survival of esophageal cancer patients receiving platinum-based therapyRumiato,E., Boldrin Daniela, Malacrida,S., Battaglia,G., Chiarion-Sileni Vanna, Ruol,A., Amadori Alberto, Saggioro DanielaPharmacogenomics
Predicting steady-state endoxifen plasma concentrations in breast cancer patients by CYP2D6 genotyping or phenotyping. Which approach is more reliable?Gusella,M., Pasini,F., Corso,B., Bertolaso,L., De Rosa,G., Falci Cristina, Modena,Y., Barile,C., Da Corte,Z. D., Fraccon,A., Toso,S., Cretella,E., Brunello Antonella, Modonesi,C., Segati,R., Oliani,C., Minicuci,N., Padrini,R., Italian TAM GroupPharmacology Research & Perspectives
Free-to-use DIR solutions in radiotherapy: Benchmark against commercial platforms through a contour-propagation studyScaggion Alessandro, Fiandra,C., Loi,G., Vecchi,C., Fusella MarcoPhysica Medica
Typical values for pediatric interventional cardiology catheterizations: A standardized approach towards Diagnostic Reference Level establishmentDe Monte Francesca, Castaldi,B., Branchini,M., Bettinelli Andrea, Milanesi,O., Paiusco Marta, Roggio AntonellaPhysica Medica
Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literatureLizzul,L., Lombardi Giuseppe, Barbot,M., Ceccato,F., Gardiman,M. P., Regazzo,D., Bellu,L., Mazza,E., Losa,M., Scaroni,C.Pituitary
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with SorafenibCaputo,F., Dadduzio Vincenzo, Tovoli,F., Bertolini,G., Cabibbo,G., Cerma,K., Vivaldi,C., Faloppi,L., Rizzato,M. D., Piscaglia,F., Celsa,C., Fornaro,L., Marisi,G., Conti,F., Silvestris,N., Silletta,M., Lonardi Sara, Granito,A., Stornello,C., Massa,V. (...)PLoS ONE
The prognostic value of pain in castration-sensitive prostate cancerIacovelli,R., Ciccarese,C., Caffo,O., De Giorgi,U., Tucci,M., Mosillo,C., Bimbatti Davide, Pierantoni,F., Maines,F., Casadei,C., Buttigliero,C., Milella,M., Tortora,G.Prostate cancer and prostatic diseases
Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRMPediconi,F., Galati,F., Bernardi,D., Belli,P., Brancato,B., Calabrese,M., Camera,L., Carbonaro,L. A., Caumo Francesca, Clauser,P., Girardi,V., Iacconi,C., Martincich,L., Panizza,P., Petrillo,A., Schiaffino,S., Tagliafico,A., Trimboli,R. M., Zuiani,C., Sardanelli,F. (...)Radiologia Medica
Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapyCecchin,E., De Mattia,E., Dreussi,E., Montico,M., Palazzari,E., Navarria,F., Bergamo Francesca, Belluco,C., Quartuccio,L., De Vita,S., Canzonieri,V., Gagno,S., Zanusso,C., Buonadonna,A., Pucciarelli,S., De Paoli,A., Toffoli,G.Radiotherapy and Oncology
Functional properties and sequence variation of HTLV-1 p13Omsland,M., Silic-Benussi Micol, Moles,R., Sarkis,S., Purcell,D. F. J., Yurick,D., Khoury,G., D'Agostino,D. M., Ciminale Vincenzo, Franchini,G.Retrovirology
Ablation of soft tissue tumours by long needle variable electrode-geometry electrochemotherapy: final report from a single-arm, single-centre phase-2 studySimioni,A., Valpione,S., Granziera Elisa, Rossi,C. R., Cavallin,F., Spina Romina, Sieni,E., Aliberti,C., Stramare,R., Campana,L. G.Scientific Reports
Age-independent increasing prevalence of Human Papillomavirus-driven oropharyngeal carcinomas in North-East ItalyDel Mistro Annarosa, Frayle - Salamanca Helena, Menegaldo,A., Favaretto,N., GORI SILVIA, Nicolai,P., Spinato,G., Romeo,S., Tirelli,G., da Mosto,M. C., Polesel,J., Boscolo Rizzo,P.Scientific Reports
An objective comparison of detection and segmentation algorithms for artefacts in clinical endoscopyAli,S., Zhou,F., Braden,B., Bailey,A., Yang,S., Cheng,G., Zhang,P., Li,X., Kayser,M., Soberanis-Mukul,R., Albarqouni,S., Wang,X., Wang,C., Watanabe,S., Oksuz,I., Ning,Q., Yang,S., Khan,M. A., Gao,X. W., Realdon Stefano (...)Scientific Reports
Biomimetic cellular vectors for enhancing drug delivery to the lungsEvangelopoulos,M., Yazdi,I. K., Acciardo,S., Palomba,R., Giordano,F., Pasto' Anna, Sushnitha,M., Martinez,J. O., Basu,N., Torres,A., Hmaidan,S., Parodi,A., Tasciotti,E.Scientific Reports
Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancerBarat,A., Smeets,D., Moran,B., Zhang,W., Cao,S., Das,S., Klinger,R., Betge,J., Murphy,V., Bacon,O., Kay,E. W., Van Grieken,N. C. T., Verheul,H. M. W., Gaiser,T., Schulte,N., Ebert,M. P., Fender,B., Hennessy,B. T., McNamara,D. A., O'Connor,D. (...)Scientific Reports
Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane AntigenCarpanese Debora, Ferro-Flores,G., Ocampo-Garcia,B., Santos-Cuevas,C., Salvarese,N., Figini,M., Fracasso,G., De Nardo,L., Bolzati,C., Rosato Antonio, Melendez-Alafort LauraScientific Reports
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast CancerPantano,F., Rossi Elisabetta, Iuliani,M., Facchinetti Antonella, Simonetti,S., Ribelli,G., Zoccoli,A., Vincenzi,B., Tonini,G., Zamarchi Rita, Santini,D.Scientific Reports
Segregation analysis of the BRCA2 c.9227G>T variant in multiple families suggests a pathogenic role in breast and ovarian cancer predispositionAgata Simona, Tognazzo Silvia, Alducci Elisa, Matricardi Laura, Moserle Lidia, Barana,D., Montagna MarcoScientific Reports
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastasesBasso,M., Corallo,S., Calegari,M. A., Zurlo,I. V., Ardito,F., Vellone,M., Marchesani,S., Orlandi,A., Dadduzio Vincenzo, Fucà ,G., Di Dio,C., Mele,C., Barbaro,B., Strippoli,A., Coppola,A., Cassano,A., Bria,E., Barone,C. A., Giuliante,F.Scientific Reports
Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancerBanna,G. L., Urzia,V., Benanti,C., Pitrè,A., Lipari,H., Di Quattro,R., De Giorgi,U., Schepisi,G., Basso Umberto, Bimbatti,D., Rundo,F., Libra,M., Malatino,L.Supportive Care in Cancer
QOLEC2: a randomized controlled trial on nutritional and respiratory counseling after esophagectomy for cancerPinto Eleonora, Nardi Maria Teresa, Marchi,R., Cavallin,F., Alfieri Rita, Saadeh,L., Cagol BREAST UNIT Matteo, Baldan,I., Saraceni,E., Parotto,M., Baratto,F., Caberlotto,C., Vianello,A., Castoro,C., Scarpa,M.Supportive Care in Cancer
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panelLorusso,D., Bologna,A., Cecere,S. C., De Matteis,E., Scandurra,G., Zamagni,C., Arcangeli,V., Artioli,F., Bella,M., Blanco,G., Cardalesi,C., Casartelli,C., De Vivo,R., Di Napoli,M., Gisone,E. B., Lauria,R., Lissoni,A. A., Loizzi,V., Maccaroni,E., Mangili,G. (...)Supportive Care in Cancer
Oncological outcome of videoscopic groin dissection for lymph node metastasis from melanomaSommariva Antonio, Cona,C., Tonello Marco, Pilati Pierluigi, Rossi Carlo RiccardoSurgical Endoscopy and Other Interventional Techniques
Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional AnalysisIacovelli,R., Ciccarese,C., Facchini,G., Milella,M., Urbano,F., Basso Umberto, De Giorgi,U., Sabbatini,R., Santini,D., Berardi,R., Santoni,M., Bracarda,S., Massari,F., Masini,C., De Tursi,M., Ricotta,R., Buti,S., Zustovich,F., Sepe,P., Rossetti,S. (...)Targeted Oncology
Real-world data for direct stage-specific costs of melanoma healthcareBuja,A., Rivera,M., De Polo,A., Zorzi,M., Carpin,E., Vecchiato Antonella, Del Fiore Santo Paolo, Martin,G., Saia,M., Baldo,V., Rugge,M., Rossi Carlo RiccardoThe British journal of dermatology
The prognostic impact of the extent of ulceration in patients with clinical stage I-II melanoma: a multicentre study of the Italian Melanoma Intergroup (IMI)Portelli,F., Galli,F., Cattaneo,L., Cossa,M., De Giorgi,V., Forte,G., Fraternali Orcioni,G., Gianatti,A., Indini,A., Labianca,A., Maurichi,A., Merelli,B., Montesco, MC., Occelli,M., Patuzzo,R., Piazzalunga,D., Pigozzo Jacopo, Quaglino,P., Ribero,S., Salvatori,R. (...)The British journal of dermatology
Eslicarbazepine in patients with brain tumor-related epilepsy: a single-center experienceZoccarato,M., Basile,A. M., Padovan Maria, Caccese Mario, Zagonel Vittorina, Lombardi GiuseppeThe International journal of neuroscience
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping MutationsPaik,P. K., Felip,E., Veillon,R., Sakai,H., Cortot,A. B., Garassino,M. C., Mazieres,J., Viteri,S., Senellart,H., Van Meerbeeck,J., Raskin,J., Reinmuth,N., Conte PierFranco, Kowalski,D., Cho,B. C., Patel,J. D., Horn,L., Griesinger,F., Han,J. Y., Kim,Y. C. (...)The New England Journal of Medicine
Complete radiological response to first-line regorafenib in a patient with abdominal relapse of BRAF V600E mutated GISTNannini,M., Valerio,D. S., Gruppioni,E., Altimari,A., Chiusole Benedetta, Saponara,M., Pantaleo,M. A., Brunello AntonellaTherapeutic advances in gastroenterology
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial)Gelsomino,F., Lamberti,G., Tiseo,M., Rocco,D., Pasello Giulia, Cecere,F. L., Chella,A., Grilli,G., Mandruzzato,M., Tognetto,M., Garassino,M. C., Macerelli,M., Novello,S., Roila,F., Colantonio,I., Grossi,F., Fiorentino,M., Ardizzoni,A.Therapeutic advances in medical oncology
Corneal side effects induced by EGFR-inhibitor antibody-drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy studyParrozzani,R., Lombardi Giuseppe, Midena,E., Leonardi,F., Londei,D., Padovan,M., Caccese Mario, Marchione,G., Bini,S., Zagonel Vittorina, Frizziero,L.Therapeutic advances in medical oncology
Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trialBarni,S., Rosati,G., Lonardi Sara, Pella,N., Banzi,M., Zampino,M. G., Dotti,K. F., Rimassa,L., Marchetti,P., Maiello,E., Artioli,F., Ferrari,D., Labianca,R., Bidoli,P., Zaniboni,A., Sobrero,A., Iaffaioli,V., De Placido,S., Frassineti,G. L., Ciarlo,A. (...)Therapeutic advances in medical oncology
First-line immune-chemotherapy combination for squamous NSCLC is already a realityHendriks,L. E. L., Menis Jessica, Remon,J.Translational lung cancer research
Pediatric sarcomas display a variable EpCAM expression in a histology-dependent mannerTombolan,L., Rossi Elisabetta, Zin,A., Santoro,L., Bonvini,P., Zamarchi Rita, Bisogno,G.Translational oncology
Management of anemia in patients with cancer: 2019 Italian Association of Medical Oncology (AIOM) guidelinesSbrana,A., Antonuzzo,A., Brunello Antonella, Petrelli,F., Pronzato,P., Tralongo,A., Turrini,M., Zoratto,F., Danova,M.Tumori Journal
Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysisMammana,M., Bergamo Francesca, Procaccio,L., Schiavon,M., Loupakis Fotios, Lonardi Sara, Manai Chiara, Schirripa Marta, Fassan,M., Dei Tos,A. P., Calabrese,F., Rea,F., Zagonel VittorinaTumori Journal
Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiencyBarresi,L., Tacelli,M., Crinò. F., Attili,F., Petrone,M. C., De Nucci,G., Carrara,S., Manfredi,G., Capurso,G., De Angelis,C. G., Crocellà ,L., Fantin Alberto, Dore,M. F., Garribba,A. T., Tarantino,I., De Pretis,N., Pagliari,D., Rossi,G., Manes,G., Preatoni,P. (...)United European Gastroenterology Journal
Wnt/?-Catenin and Hippo Pathway Deregulation in Mammary Tumors of Humans, Dogs, and CatsSammarco,A., Gomiero,C., Sacchetto,R., Beffagna,G., Michieletto Silvia, Orvieto,E., Cavicchioli,L., Gelain,M. E., Ferro,S., Patruno,M., Zappulli,V.Veterinary Pathology
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR studyGacci,M., Artibani,W., Bassi,P., Bertoni,F., Bracarda,S., Briganti,A., Carmignani,G., Carmignani,L., Conti,G., Corvò,R., De Nunzio,C., Fusco,F., Graziotti,P., Greco,I., Maggi,S., Magrini,S. M., Mirone,V., Montironi,R., Morgia,G., Muto,G. (...)World journal of urology

Dati aggiornati al 27 agosto 2020.